(1)
Comparison of Panretinal Photocoagulation Alone With Panretinal Photocoagulation Plus Intravitreal Bevacizumab in Treatment of High Risk Proliferative Diabetic Retinopathy. J Fatima Jinnah Med Univ 2018, 10 (1).